| # | Drug | Count |
|---|---|---|
| 0 | TIRZEPATIDE | 59 |
| 1 | ORAL SEMAGLUTIDE | 37 |
| 2 | ADALIMUMAB | 27 |
| 3 | ONABOTULINUMTOXINA | 21 |
| 4 | HYALURONIDASE | 12 |
| 5 | DENOSUMAB | 11 |
| 6 | METFORMIN | 11 |
| 7 | METFORMIN ER 500 MG | 11 |
| 8 | METFORMIN ER 750 MG | 11 |
| 9 | ASFOTASE ALFA | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LETIBOTULINUMTOXINA-WLBG | 1 | 0.0034 |
| 1 | TESAMORELIN | 3 | 0.0018 |
| 2 | BEMPEDOIC ACID AND EZETIMIBE | 1 | 0.0014 |
| 3 | L-LYSINE | 1 | 0.0014 |
| 4 | FENOFIBRIC ACID | 1 | 0.0013 |
| 5 | 12%AZELAIC ACID | 1 | 0.0012 |
| 6 | HISTRELIN ACETATE | 1 | 0.0011 |
| 7 | AZELAIC ACID | 1 | 0.0010 |
| 8 | ASFOTASE ALFA | 9 | 0.0009 |
| 9 | HYALURONIC ACID | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 106 |
| 1 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 59 |
| 2 | Acetylcholine Release Inhibitor [EPC] | 27 |
| 3 | Neuromuscular Blocker [EPC] | 27 |
| 4 | Cytolytic Agent [EPC] | 23 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 17 |
| 6 | Provitamin D2 Compound [EPC] | 16 |
| 7 | Endoglycosidase [EPC] | 12 |
| 8 | RANK Ligand Inhibitor [EPC] | 11 |
| 9 | Vitamin C [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Cytolytic Agent [EPC] | 23 | 0.0099 |
| 1 | Endoglycosidase [EPC] | 12 | 0.0065 |
| 2 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 9 | 0.0009 |
| 3 | Provitamin D2 Compound [EPC] | 16 | 0.0005 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 5 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 1 | 0.0003 |
| 6 | Acetylcholine Release Inhibitor [EPC] | 27 | 0.0003 |
| 7 | Ectoparasiticide [EPC] | 1 | 0.0003 |
| 8 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 9 | GLP-1 Receptor Agonist [EPC] | 106 | 0.0002 |